UniQure's Embattled Huntington's Gene Therapy Clears A Key Hurdle

Uniqure stock wavered Wednesday after the Food and Drug Administration accepted its application for approval of a Huntington's gene therapy. The post UniQure's Embattled Huntington's Gene Therapy Clears A Key Hurdle appeared first on Investor's Business Daily.